THOMAS PIEBER / ELYTE DIAGNOSTICS

Elyte Diagnostics.
From an idea to innovation.

Thomas Pieber is an investor and the originator of the research idea behind the project. The focus: developing potassium self-testing for use at home.

A medical question as a starting point

People with heart or kidney failure may face an increased risk of potassium imbalances. Elyte Diagnostics addresses the question of how potassium monitoring could be integrated more easily into daily life.

KaliumForMe: the diagnostic approach

Elyte is developing KaliumForMe as a point-of-care system to determine potassium concentrations in capillary blood. The approach combines optical sensing with a small blood sample and aims to enable independent testing at home.

Visit the official Elyte website

Thomas Pieber’s role

The research idea was originated by Thomas Pieber. As an investor, he supports the project at the intersection of medicine, research and diagnostic innovation. This description of his role is based on information approved by the client.

ELYTE DIAGNOSTICS / FOR INVESTORS

For investors interested in enabling medical innovation

A personal conversation can explore the scientific basis and development perspective of Elyte Diagnostics. Topics relevant to assessing a potential investment include:

01

Science & evidence

The sensing principle, clinical question and available study data.

02

Development & regulation

Product development, validation and the next regulatory steps.

03

Execution & investment

The application model, partnerships and possible investment opportunities.

This website contains no investment offer, financing terms or promise of returns. Potential investments and non-public project information must be discussed personally.